TickerFactsScreenerDevelopers

REGENXBIO Inc. (RGNX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2017: $1.71M2018: $9.64M2019: $8.24M2020: $35.71M2021: $51.83M2022: $54.55M2023: $37.21M2024: $33.57M$33.57M
2017Cost of Revenue (USD)2024
Fiscal YearCost of RevenueChange YoY
2024$33.57M-9.8%
2023$37.21M-31.8%
2022$54.55M+5.2%
2021$51.83M+45.1%
2020$35.71M+333.4%
2019$8.24M-14.5%
2018$9.64M+464.1%
2017$1.71M—